(R)-2-Amino-N-(1-((5,5'-diallyl-2,2'-dihydroxy-[1,1'-biphenyl]-3-yl)methyl)piperidin-4-yl)propenamide

ID: ALA4757378

PubChem CID: 162657112

Max Phase: Preclinical

Molecular Formula: C27H35N3O3

Molecular Weight: 449.60

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCc1ccc(O)c(-c2cc(CC=C)cc(CN3CCC(NC(=O)[C@@H](C)N)CC3)c2O)c1

Standard InChI:  InChI=1S/C27H35N3O3/c1-4-6-19-8-9-25(31)23(15-19)24-16-20(7-5-2)14-21(26(24)32)17-30-12-10-22(11-13-30)29-27(33)18(3)28/h4-5,8-9,14-16,18,22,31-32H,1-2,6-7,10-13,17,28H2,3H3,(H,29,33)/t18-/m1/s1

Standard InChI Key:  JPUSCPOPXQNQLZ-GOSISDBHSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
   32.1703  -17.6232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1692  -18.4428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8772  -18.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5869  -18.4423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5841  -17.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8754  -17.2144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2917  -18.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2917  -19.6673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9992  -20.0747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7072  -19.6650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7033  -18.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9952  -18.4398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2914  -17.2062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.5833  -20.0748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4612  -18.8508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7538  -18.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0457  -18.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4089  -18.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1187  -18.8363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8243  -18.4241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8730  -16.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1641  -15.9907    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1642  -15.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4594  -14.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7505  -15.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7510  -15.9890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4603  -16.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0414  -14.7615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3337  -15.1702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6260  -14.7616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3338  -15.9874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6259  -13.9445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9183  -15.1703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4  7  1  0
  5 13  1  0
  8 14  1  0
  2 15  1  0
 15 16  1  0
 16 17  2  0
 11 18  1  0
 18 19  1  0
 19 20  2  0
  6 21  1  0
 21 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  1
 30 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757378

    ---

Associated Targets(Human)

HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.60Molecular Weight (Monoisotopic): 449.2678AlogP: 3.65#Rotatable Bonds: 9
Polar Surface Area: 98.82Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 7.67CX Basic pKa: 9.47CX LogP: 2.59CX LogD: 1.28
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: 0.05

References

1. Zhao M,Zheng YH,Zhao QY,Zheng W,Yang JH,Pei HY,Liu L,Liu KJ,Xue LL,Deng DX,Wang L,Ma X,Fu SH,Peng AH,Tang MH,Luo YZ,Ye HY,Chen LJ.  (2021)  Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.,  209  [PMID:33069436] [10.1016/j.ejmech.2020.112922]

Source